Zhimeng Wu

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 19

Top Topics

Regulatory T Cells

Hyaluronic Acid

Staphylococcus Aureus

Metastatic Colorectal Cancer

Top Venues

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Chemical science

Journal of medicinal chemistry

Nanoscale advances

This page only lists publications with an associated author ORCID identifier.

Publications

Yanchun Li, Han Lin, Haofei Hong, Dan Li, Liang Gong, Jie Zhao, Zheng Wang, Zhimeng Wu
Multivalent Rhamnose-Modified EGFR-Targeting Nanobody Gains Enhanced Innate Fc Effector Immunity and Overcomes Cetuximab Resistance via Recruitment of Endogenous Antibodies. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (13) (2024)
Yanchun Li, Han Lin, Haofei Hong, Dan Li, Liang Gong, Jie Zhao, Zheng Wang, Zhimeng Wu
Multivalent Rhamnose-Modified EGFR-Targeting Nanobody Gains Enhanced Innate Fc Effector Immunity and Overcomes Cetuximab Resistance via Recruitment of Endogenous Antibodies. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024)
Yanchun Li, Han Lin, Haofei Hong, Dan Li, Liang Gong, Jie Zhao, Zheng Wang, Zhimeng Wu
Multivalent Rhamnose-Modified EGFR-Targeting Nanobody Gains Enhanced Innate Fc Effector Immunity and Overcomes Cetuximab Resistance via Recruitment of Endogenous Antibodies. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (13) (2024)
Yanchun Li, Han Lin, Haofei Hong, Dan Li, Liang Gong, Jie Zhao, Zheng Wang, Zhimeng Wu
Multivalent Rhamnose-Modified EGFR-Targeting Nanobody Gains Enhanced Innate Fc Effector Immunity and Overcomes Cetuximab Resistance via Recruitment of Endogenous Antibodies. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (13) (2024)
Rui Gao, Xinxin Xu, Zhimeng Wu, Liguang Xu, Hua Kuang, Chuanlai Xu
The potential of converting carbon dioxide to food compounds via asymmetric catalysis. Nanoscale advances 5 (11) (2023)
Mingming Lu, Yating Zhu, Dan Li, Zhifang Zhou, Han Lin, Haofei Hong, Jie Shi, Zhimeng Wu
Gb3-Coated Bovine Milk Exosomes as a Practical Neutralizer for Shiga Toxin. ACS applied bio materials (2023)
Haofei Hong, Han Lin, Dan Li, Liang Gong, Kun Zhou, Yanchun Li, Hangyan Yu, Kai Zhao, Jie Shi, Zhifang Zhou, Zhaohui Huang, Zhimeng Wu
Chemoenzymatic Synthesis of a Rhamnose-Functionalized Bispecific Nanobody as a Bispecific Antibody Mimic for Cancer Immunotherapy. Angewandte Chemie (International ed. in English) 61 (38) (2022)
Zhongkai Lu, Zhicheng Liu, Xia Li, Xinfang Qin, Haofei Hong, Zhifang Zhou, Roland J Pieters, Jie Shi, Zhimeng Wu
Nanobody-Based Bispecific Neutralizer for Shiga Toxin-Producing E. coli . ACS infectious diseases 8 (2) (2022)
Yanchun Li, Liang Gong, Haofei Hong, Han Lin, Dan Li, Jie Shi, Zhifang Zhou, Zhimeng Wu
β-Galactosidase-dependent metabolic glycoengineering of tumor cells for imaging and immunotherapy. Chemical communications (Cambridge, England) 58 (15) (2022)
Dan Li, Liang Gong, Han Lin, Surui Yao, Yuan Yin, Zhifang Zhou, Jie Shi, Zhimeng Wu, Zhaohui Huang
Hyaluronic Acid-Coated Bovine Milk Exosomes for Achieving Tumor-Specific Intracellular Delivery of miRNA-204. Cells 11 (19) (2022)
Kun Zhou, HaoFei Hong, Han Lin, Liang Gong, Dan Li, Jie Shi, Zhifang Zhou, Fei Xu, Zhimeng Wu
Chemical Synthesis of Antibody-Hapten Conjugates Capable of Recruiting the Endogenous Antibody to Magnify the Fc Effector Immunity of Antibody for Cancer Immunotherapy. Journal of medicinal chemistry 65 (1) (2021)
Shijie Dai, Haofei Hong, Kun Zhou, Kai Zhao, Yuntian Xie, Chen Li, Jie Shi, Zhifang Zhou, Lei Nie, Zhimeng Wu
Exendin 4-Hapten Conjugate Capable of Binding with Endogenous Antibodies for Peptide Half-life Extension and Exerting Long-Acting Hypoglycemic Activity. Journal of medicinal chemistry 64 (8) (2021)
Han Lin, Kun Zhou, Dan Li, Haofei Hong, Yuntian Xie, Liang Gong, Yu Shen, Zhifang Zhou, Jie Shi, Zhimeng Wu
Dinitrophenol-Hyaluronan Conjugates as Multivalent Antibody-Recruiting Glycopolymers for Targeted Cancer Immunotherapy. ChemMedChem 16 (19) (2021)
Haofei Hong, Chen Li, Liang Gong, Jinfeng Wang, Dan Li, Jie Shi, Zhifang Zhou, Zhaohui Huang, Zhimeng Wu
Universal endogenous antibody recruiting nanobodies capable of triggering immune effectors for targeted cancer immunotherapy. Chemical science 12 (12) (2021)
Liang Gong, Yanchun Li, Kaisa Cui, Ying Chen, Haofei Hong, Jiuming Li, Dan Li, Yuan Yin, Zhimeng Wu, Zhaohui Huang
Nanobody-Engineered Natural Killer Cell Conjugates for Solid Tumor Adoptive Immunotherapy. Small (Weinheim an der Bergstrasse, Germany) 17 (45) (2021)
Gang-Long Yang, Rong Wang, Dan Li, Chenyang Zuo, Piaopiao Wen, Haili Liu, Yongquan Chen, Morihisa Fujita, Zhimeng Wu, Ganglong Yang
Comprehensive Analysis of the Glycome and Glycoproteome of Bovine Milk-Derived Exosomes. Journal of agricultural and food chemistry 68 (45) (2020)
Haofei Hong, Zhifang Zhou, Kun Zhou, Shaozhong Liu, Zhongwu Guo, Zhimeng Wu
Site-specific C-terminal dinitrophenylation to reconstitute the antibody Fc functions for nanobodies. Chemical science 10 (40) (2019)
Xiaozhong Cheng, Haofei Hong, Zhifang Zhou, Zhimeng Wu
Enzymatic On-Resin Peptide Cleavage and in Situ Cyclization One-Pot Strategy for the Synthesis of Cyclopeptide and Cyclotide. The Journal of organic chemistry 83 (22) (2018)
Min Yang, Haofei Hong, Shaozhong Liu, Xinrui Zhao, Zhimeng Wu
Immobilization of Staphylococcus aureus Sortase A on Chitosan Particles and Its Applications in Peptide-to-Peptide Ligation and Peptide Cyclization. Molecules (Basel, Switzerland) 23 (1) (2018)